FOX CHASE CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1904-01-01

Employees: -

Market Cap: -

Website: http://www.foxchase.org

Clinical Trials

Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2004-03-11

Last Posted Date: 2013-07-10

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 17

Registration Number: NCT00021359

Locations: 🇺🇸
Hunterdon Regional Cancer Center, Flemington, New Jersey, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County, Mount Holly, New Jersey, United States

and more 15 locations

Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2004-03-01

Last Posted Date: 2013-04-17

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 22

Registration Number: NCT00003264

Locations: 🇺🇸
Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States
🇺🇸
Reading Hospital and Medical Center, Reading, Pennsylvania, United States
🇺🇸
St. Francis Medical Center, Trenton, New Jersey, United States

and more 9 locations

Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma

First Posted Date: 2004-02-27

Last Posted Date: 2013-07-10

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 25

Registration Number: NCT00021372

Locations: 🇺🇸
Kimball Medical Center, Lakewood, New Jersey, United States
🇺🇸
Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States
🇺🇸
Community Medical Center, Toms River, New Jersey, United States

and more 14 locations

Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Phase 1

Completed

Conditions: Lung Cancer

First Posted Date: 2004-02-27

Last Posted Date: 2013-09-02

Lead Sponsor: Fox Chase Cancer Center

Registration Number: NCT00022308

Locations: 🇺🇸
Riverview Medical Center - Booker Cancer Center, Red Bank, New Jersey, United States
🇺🇸
Delaware County Memorial Hospital, Drexel Hill, Pennsylvania, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

and more 5 locations

Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer
Lung Cancer

First Posted Date: 2004-01-14

Last Posted Date: 2013-04-17

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 29

Registration Number: NCT00021333

Locations: 🇺🇸
St. Francis Medical Center, Trenton, New Jersey, United States
🇺🇸
Southern Chester County Medical Center, West Grove, Pennsylvania, United States
🇺🇸
Kimball Medical Center, Lakewood, New Jersey, United States

and more 15 locations

Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 1

Withdrawn

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2004-01-14

Last Posted Date: 2013-07-11

Lead Sponsor: Fox Chase Cancer Center

Registration Number: NCT00021307

Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Phase 2

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: rhuMAB-VEGF
Drug: docetaxel

First Posted Date: 2003-08-07

Last Posted Date: 2021-03-05

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 32

Registration Number: NCT00066677

Locations: 🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2003-06-25

Last Posted Date: 2013-07-11

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 21

Registration Number: NCT00006013

Locations: 🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

and more 1 locations

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Phase 2

Completed

Conditions: Leukemia
Lymphoma

First Posted Date: 2003-06-06

Last Posted Date: 2013-07-11

Lead Sponsor: Fox Chase Cancer Center

Target Recruit Count: 5

Registration Number: NCT00062296

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase 1

Completed

Conditions: Lung Cancer

First Posted Date: 2003-06-06

Last Posted Date: 2010-02-12

Lead Sponsor: Fox Chase Cancer Center

Registration Number: NCT00062322

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy